Total Funding
43
45
Total FundingPrivate Equity raised
Growth Score 43 in past quarter
-24 pts
Heat Score 45 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
50459
BioMatrix Specialty Pharmacy is a specialty pharmacy platform company.
Acquired by 

Frazier Healthcare Partners
- Kathee Kramm: President and Chief Operating OfficerPast Role: Superior Biologics, President and CEO
- William Nolan: Chief Growth Officer
About the Company
BioMatrix Specialty Pharmacy offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. BioMatrix commitment to every patient is to provide individualized pharmacy services, timely access to care, and focused education and support. It offer a
tailored approach for a wide range of therapeutic categories, improving health and empowering patients to experience a higher quality of life.

